Results for tag: "Brilinta"

Brilinta (ticagrelor) is a cardiovascular drug used to reduce the risk of heart attack and stroke in people with acute coronary syndrome (ACS). It is a platelet aggregation inhibitor, meaning it works by preventing platelets from clumping together and forming clots. It is usually prescribed in combination with aspirin and other medications. Brilinta is a newer drug, approved by the FDA in 2011, and is increasingly being used in place of older drugs such as clopidogrel. Brilinta is a part of a larger market of cardiovascular drugs, which includes medications for high blood pressure, cholesterol, and heart failure. These drugs are used to treat and prevent a variety of cardiovascular conditions, including coronary artery disease, stroke, and arrhythmias. Some companies in the Brilinta market include AstraZeneca, which manufactures the drug, as well as other pharmaceutical companies that produce generic versions of the drug. Additionally, there are many companies that specialize in the distribution and sale of cardiovascular drugs. Show Less Read more